TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Percentage of participants with no progression to IV anesthesia for 36 hours following IP initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in HCV RNA Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient preferences survey - Hip Arthritis
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient preferences survey - Knee Arthritis
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient preferences survey - hip labral tears and FAI
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient preferences survey - Osteochondritis dissecans
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient preferences survey - Achilles tendon rupture
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient preferences survey - patellofemoral dislocation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Blood levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Maximum plasma concentration (Cmax) of Valsartan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of medication errors change
Endpoint domain: Adverse events/effects
Primary endpoint: percent of adverse drug events change
Endpoint domain: Adverse events/effects
Primary endpoint: Percent of evidence-based guidelines compliance improvement
Endpoint domain: Resource use
Primary endpoint: Number of participants who discontinued study due to an AE
Endpoint domain: Adverse events/effects
Primary endpoint: Breast mass doubling time change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Extent of tumor growth via morphological information
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Extent of tumor growth via spectral THG intensity distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in spectral THG strength distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: time to deterioration of global health status (GHS) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: time to deterioration of fatigue score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Progression of Acute Kidney Injury (AKI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Leptomeningeal disease (LMD)-free rate
Endpoint domain: Mortality/survival
Primary endpoint: Methylation of the cpg sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uterine artery flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Umbilical artery flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Middle cerebral artery flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: HSIL/CIN2-3 recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Alanine aminotransferase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Aspartate aminotransferase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Geometric mean titer of JE neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: MDRO acquisition
Endpoint domain: Adverse events/effects
Primary endpoint: Low disease activity (PMR-AS<10) with steroid independence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in concentration of salivary free testosterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of Patients Without Symptomatic Myeloma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Diagnosis of duodenal adenoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Technical efficacy by medication and pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety determined by intended lesions
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of grade II-IV aGVHD
Endpoint domain: Adverse events/effects
Primary endpoint: Pain score difference at 60 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree range of motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scores of The Western Ontario and McMaster Universities Arthritis Index (WOMAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain scores visual analog scale (EVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Initial AT-III Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rate of patients with complete response CR after 2 cycles of treatment
Endpoint domain: Physiological/clinical
Primary endpoint: Predose (Trough) Plasma Concentration (C0h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Menstrual Cycle Length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of CD3/CD19 selected haplo identical hematopoietic stem cell transplant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regression of Retinopathy of Prematurity (ROP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ophthalmic outcomes
Primary endpoint: proportion of patients with mean CD4 count above or equal to baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: In-hospital procedural safety up to 7 days
Endpoint domain: Adverse events/effects
Primary endpoint: Radius of the femoropopliteal artery lumen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: changes of kidney function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Bayley-III Index Scores (Cognitive, Language, and Motor)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Peak Plasma Concentration (Cmax) of Melatonin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Newly reported hepatitis B-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: percentage of patients with different diagnostic and therapeutic attitudes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in cognitive functioning based on neurocognitive test battery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Optimal cardiac output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pain index
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Depressive mood index
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pittsburgh sleep quality index
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Kupperman Climacteric Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ISTH bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Subjective sleep quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in Subjective sleep quantity
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in Training volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arterial cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hypothalamic Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Pituitary function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Testicular Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Pouch mucosal proliferation index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pouch mucosal apoptosis index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Hemoglobin A1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of patients with detected prostate cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: leak pressure of the laryngeal masks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cause of bowel obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Duration of Breastfeeding
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Mini-AQLQ
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: patient symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Brief Symptom Inventory -18
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in the World Health Organization Quality of Life 100
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of delayed cerebral ischemia (DCI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of perfusion deficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of children completing desensitization
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Post Traumatic Stress Symptom Severity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Itch score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incidence rate of SARS-CoV-2 infection
Endpoint domain: Adverse events/effects
Primary endpoint: Change in ASIA motor score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Yale global tic severity scale (YTGSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Suicidal Ideation and Behavior at One Month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suicidal Ideation and Behavior at Three Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vital Statistics (Suicide death)
Endpoint domain: Mortality/survival
Primary endpoint: Maternal diagnosis of hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Self-reported Mixed Urinary Incontinence Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Recurrence of Urinary Tract Infections (UTIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Pulmonary arterial pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change From Period Baseline in FEV1 (L) AUC(0-24h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Objective response rate (percentage of patients with CR or PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of cCMV infection in newborns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Peak Aerosol Particle Concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Minute Ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Carbon Dioxide Output
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CSF Aβ40 and Aβ42 concentration at maximum change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of Muscle Protein Synthesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lipid Tolerance Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: EndoPAT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Breast Q questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: VAS scale
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: MHHS scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cardiovascular risk factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Hamilton Depression Rating Scale (HAM-D 17) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Response of Bone Marrow Micrometastases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Trust Game Affect Ratings
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Functional Ambulation Profile (FAP) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of temporomandibular joint effusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total lung glycolysis (TLG) on PET/CT imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scored cosmetic appearance by blinded physician
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scored cosmetic appearance by patient
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient self reported comfort with placement of either sutures or staples
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Composite endpoint of cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Major bleeding defined by the ISTH criteria
Endpoint domain: Adverse events/effects
Primary endpoint: dynamic changes of plasma ctDNA mutant copies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: CFU Density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Glucose Metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of Lipid Metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hepatic Sensitivity to Low Dose Insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Peripheral Sensitivity to High Dose Insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Sustained Virological Response at Week 24 (SVR24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Platelet Counts of ≥ 100,000/mcL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Limb Occlusion Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Nutritional Risk Screening score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Recruitment percentage of eligible subjects
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Retention percentage of participants at end-of-study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Non-attendance rates of participants
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: changes in serum level of interleukin 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: changes in serum level of interleukin 10
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Objective Outcome Measures (Steps, Distance Travelled)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Satisfaction with their Spine Care
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: CPR skills assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Basal Metabolic Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cardiopostural Control (heart rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardiopostural Control (systolic blood pressure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardiopostural Control (diastolic blood pressure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Strength test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Subjective instability test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved classroom social pragmatics
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Improved executive functioning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Total score of MADRS
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Neuroimaging Markers of Brain Structures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neuroimaging Markers of Brain Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognitive Status
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Child BMIz Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PaCO2 stabilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Difference in aggregation induced by agonist collagen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Difference in aggregation induced by agonist arachidonic acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Difference in aggregation induced by agonist adenosine diphosphate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Difference in aggregation measured by VerifyNow® Aggregometry using the ASPI-kit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Difference in aggregation measured by VerifyNow® Aggregometry using the P2Y12-kit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Post Traumatic Stress Disorder (PTSD) Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Level of Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in suppressive capacity of circulating regulatory T cells at 30 days post-treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in suppressive capacity of circulating regulatory T cells at 60 days post-treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in suppressive capacity of circulating regulatory T cells at 120 days post-treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: In vivo mitochondrial capacity (ATPmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of reoperation due to meniscal repair failure
Endpoint domain: Adverse events/effects
Primary endpoint: Illicit-positive urines
Endpoint domain: Adverse events/effects
Primary endpoint: Peak Plasma Concentration (Cax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regression of white matter lesion load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of Participants With Clinically Evident Post-Operative Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Prophylactic peak anti-Xa level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Pathological response time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Reduction in Oxygen Requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Hemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Average nightly hours of CPAP use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circulating FGF21
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Triglyceride concentration in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Response rate as measured by scans and tumor measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Fixation to bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in ADAS-COG11 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: System Performance with respect to YSI reference venous plasma sample measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes